These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Brain metastases in breast cancer: prognostic factors and management. Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100 [TBL] [Abstract][Full Text] [Related]
8. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options. Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977 [TBL] [Abstract][Full Text] [Related]
9. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy. Ekenel M; Iwamoto FM; Ben-Porat LS; Panageas KS; Yahalom J; DeAngelis LM; Abrey LE Cancer; 2008 Sep; 113(5):1025-31. PubMed ID: 18618509 [TBL] [Abstract][Full Text] [Related]
10. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation. Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045 [TBL] [Abstract][Full Text] [Related]
11. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588 [TBL] [Abstract][Full Text] [Related]
12. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system. Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848 [TBL] [Abstract][Full Text] [Related]
13. Results of treatment of 112 cases of primary CNS lymphoma. Yamanaka R; Morii K; Shinbo Y; Homma J; Sano M; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Kakuma T; Tanaka R Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337 [TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma of the central nervous system: a clinicopathological review. Al-Sobhi E; Osoba AO; Karar A; Zuraiki AM East Mediterr Health J; 2009; 15(6):1570-9. PubMed ID: 20218151 [TBL] [Abstract][Full Text] [Related]
15. Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant. Cheema PK; Zadeh S; Kukreti V; Reece D; Chen C; Trudel S; Mikhael J Biol Blood Marrow Transplant; 2009 Jun; 15(6):686-93. PubMed ID: 19450753 [TBL] [Abstract][Full Text] [Related]